Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Sirukumab: data from SIRROUND-D

June 15, 2016

Symic Biomedical reports treatment of first patient with SB-061

June 14, 2016

Eisai presents latest phase I/II data for E-6011 in rheumatoid arthritis and Crohn's disease

June 14, 2016

GS-9876: preclinical data

June 14, 2016

Biosimilar rituximab GP-2013 shows bioequivalence

June 14, 2016

FDA will review biosimilar application for Amgen's adalimumab

June 14, 2016

Preliminary phase I data for milatuzumab

June 13, 2016

Crispr Therapeutics and Anagenesis Biotechnologies enter collaboration for P2MC technology

June 9, 2016

Pfizer announces phase II results of tofacitinib citrate

June 8, 2016

Can-Fite reaches agreement with EMA for piclidenoson phase III trial

June 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...